First Patient Treated in MEDIPOST Trial of Stem Cell Therapy
The U.S. Phase III trial expands the investigation of umbilical cord therapy for symptomatic cartilage defects due to knee OA....
The U.S. Phase III trial expands the investigation of umbilical cord therapy for symptomatic cartilage defects due to knee OA....
VB Spine intends to make CT-Fluoro technology available as part of its technology offerings for spine procedures. ...
The platform is designed to address the operational barriers that may limit minimally invasive spine surgery....
The implant is a knitted surgical scaffold in the form of a band intended to provide fixation during the healing...
In this video we look at the prospects for a U.S. knee replacement rebound, the move to smaller technology, and...
We spoke with OrthAlign's Eric Timko about technology trends, Lantern ASC and company's move into the European market....
The naturally-derived hyaluronic acid and alginate hydrogel is designed to provide a conformable, bioresorbable gliding interface....
Lantern ASC includes a reusable navigation unit paired with a procedural Smart Pack Kit to integrate into existing surgical workflows....
NanoCept coating technology is intended to mitigate bacterial contamination on the implant surface prior to implantation....
The gross proceeds from the private placement, before fees are deducted, are expected to be approximately $2.6 million....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.